William Blair & Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-116,433
| Closed | -$830K | – | 1781 |
|
|
2020
Q1 | $830K | Sell |
116,433
-48,016
| -29% | -$342K | 0.01% | 722 |
|
|
2019
Q4 | $3.93M | Buy |
164,449
+11,795
| +8% | +$282K | 0.02% | 445 |
|
|
2019
Q3 | $4.09M | Buy |
152,654
+5,105
| +3% | +$137K | 0.02% | 414 |
|
|
2019
Q2 | $4M | Buy |
147,549
+9,266
| +7% | +$251K | 0.02% | 422 |
|
|
2019
Q1 | $4.8M | Buy |
138,283
+29,985
| +28% | +$1.04M | 0.03% | 378 |
|
|
2018
Q4 | $2.11M | Buy |
108,298
+20,107
| +23% | +$392K | 0.02% | 514 |
|
|
2018
Q3 | $2.35M | Buy |
88,191
+3,484
| +4% | +$92.8K | 0.01% | 525 |
|
|
2018
Q2 | $3.2M | Buy |
84,707
+14,835
| +21% | +$560K | 0.02% | 460 |
|
|
2018
Q1 | $2.28M | Buy |
69,872
+17,409
| +33% | +$569K | 0.02% | 525 |
|
|
2017
Q4 | $2.55M | Buy |
52,463
+7,869
| +18% | +$383K | 0.02% | 512 |
|
|
2017
Q3 | $2.41M | Buy |
44,594
+12,994
| +41% | +$702K | 0.02% | 513 |
|
|
2017
Q2 | $1.78M | Sell |
31,600
-7,126
| -18% | -$400K | 0.01% | 596 |
|
|
2017
Q1 | $1.34M | Buy |
38,726
+18,105
| +88% | +$628K | 0.01% | 631 |
|
|
2016
Q4 | $463K | Sell |
20,621
-3,000
| -13% | -$67.4K | ﹤0.01% | 852 |
|
|
2016
Q3 | $536K | Buy |
23,621
+9,421
| +66% | +$214K | ﹤0.01% | 800 |
|
|
2016
Q2 | $335K | Buy |
+14,200
| New | +$335K | ﹤0.01% | 941 |
|